04/22/2024
4:05 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form PRE 14A | |
04/02/2024
6:30 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:31 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
3:42 PM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
6:00 PM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
6:03 PM | Kontulis Caitlin (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:30 AM | INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
12/28/2023
8:13 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B3 | |
12/27/2023
11:15 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form EFFECT | |
12/19/2023
3:52 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/19/2023
12:07 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/08/2023
4:00 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
6:00 PM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
3:30 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/21/2023
6:30 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
8:30 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B3 | |
06/19/2023
11:15 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form EFFECT | |
06/13/2023
3:40 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/09/2023
3:31 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form DEFA14A | |
06/09/2023
3:32 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form ARS | |
06/02/2023
3:30 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
4:00 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
05/24/2023
6:35 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2023
6:35 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
4:01 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
4:02 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
3:30 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B3 | |
05/09/2023
11:15 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form EFFECT | |
